Comparing Outcomes of Patients With Idiopathic Subarachnoid Hemorrhage by Stratifying Perimesencephalic Bleeding Patterns.


Journal

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association
ISSN: 1532-8511
Titre abrégé: J Stroke Cerebrovasc Dis
Pays: United States
ID NLM: 9111633

Informations de publication

Date de publication:
Sep 2019
Historique:
received: 05 06 2019
revised: 14 06 2019
accepted: 24 06 2019
pubmed: 16 7 2019
medline: 3 9 2019
entrez: 16 7 2019
Statut: ppublish

Résumé

To determine the clinical outcomes of perimesencephalic subarachnoid hemorrhages based on the computed tomography (CT) bleeding patterns. This retrospective cohort study included: (1) patients (≥18 years) admitted to a comprehensive stroke center (January 2015-May 2018), (2) with angiography-negative, nontraumatic subarachnoid hemorrhage in a perimesencephalic or diffuse bleeding pattern, and (3) had CT imaging performed in ≤ 72 hours of symptom onset. Patients were stratified by location of bleeding on CT: Peri-1: focal prepontine hemorrhage; Peri-2: prepontine with suprasellar cistern +/- intraventricular extension; and diffuse. Of the 39 patients included, 13 were Peri-1, 11 were Peri-2, and 15 were diffuse. The majority were male (n = 26), with a mean (standard deviation) age of 55.3 (11.3) years, who often presented with headache (n = 37) and nausea (n = 28). Overall, patients in Peri-1 were significantly less likely to have hydrocephalus compared to Peri-2 and dSAH (P= .003), and 4 patients required an external ventricular drain. Five patients developed symptomatic vasospasm. Patients in Peri-1, compared to Peri-2 and diffuse, had a significantly shorter median neuro critical care unit length of stay (LOS) and hospital LOS. Most patients (n = 35) had a discharge modified Rankin Score between 0 and 2 with no significant differences found between groups. These data suggest that patients with the best clinical course were those in Peri-1, followed by Peri-2, and then diffuse. Because these patients often present with similar clinical signs, stratifying by hemorrhage pattern may help clinicians predict which patients with perimesencephalic subarachnoid hemorrhage develop complications.

Sections du résumé

BACKGROUND BACKGROUND
To determine the clinical outcomes of perimesencephalic subarachnoid hemorrhages based on the computed tomography (CT) bleeding patterns.
METHODS METHODS
This retrospective cohort study included: (1) patients (≥18 years) admitted to a comprehensive stroke center (January 2015-May 2018), (2) with angiography-negative, nontraumatic subarachnoid hemorrhage in a perimesencephalic or diffuse bleeding pattern, and (3) had CT imaging performed in ≤ 72 hours of symptom onset. Patients were stratified by location of bleeding on CT: Peri-1: focal prepontine hemorrhage; Peri-2: prepontine with suprasellar cistern +/- intraventricular extension; and diffuse.
RESULTS RESULTS
Of the 39 patients included, 13 were Peri-1, 11 were Peri-2, and 15 were diffuse. The majority were male (n = 26), with a mean (standard deviation) age of 55.3 (11.3) years, who often presented with headache (n = 37) and nausea (n = 28). Overall, patients in Peri-1 were significantly less likely to have hydrocephalus compared to Peri-2 and dSAH (P= .003), and 4 patients required an external ventricular drain. Five patients developed symptomatic vasospasm. Patients in Peri-1, compared to Peri-2 and diffuse, had a significantly shorter median neuro critical care unit length of stay (LOS) and hospital LOS. Most patients (n = 35) had a discharge modified Rankin Score between 0 and 2 with no significant differences found between groups.
CONCLUSION CONCLUSIONS
These data suggest that patients with the best clinical course were those in Peri-1, followed by Peri-2, and then diffuse. Because these patients often present with similar clinical signs, stratifying by hemorrhage pattern may help clinicians predict which patients with perimesencephalic subarachnoid hemorrhage develop complications.

Identifiants

pubmed: 31303438
pii: S1052-3057(19)30301-5
doi: 10.1016/j.jstrokecerebrovasdis.2019.06.032
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2407-2413

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Benjamin Atchie (B)

Department of Neurology, Swedish Medical Center, Englewood, CO; Radiology Imaging Associates, Englewood, CO.

Constance McGraw (C)

Department of Trauma Research, Swedish Medical Center, Englewood, CO.

Kathryn McCarthy (K)

Department of Neurology, Swedish Medical Center, Englewood, CO; Blue Sky Neurology, Englewood, CO.

Rebecca van Vliet (R)

Department of Neurology, Swedish Medical Center, Englewood, CO; Blue Sky Neurology, Englewood, CO.

Donald Frei (D)

Department of Neurology, Swedish Medical Center, Englewood, CO; Radiology Imaging Associates, Englewood, CO.

Alicia Bennett (A)

Department of Neurology, Swedish Medical Center, Englewood, CO; Blue Sky Neurology, Englewood, CO.

Russell Bartt (R)

Department of Neurology, Swedish Medical Center, Englewood, CO; Blue Sky Neurology, Englewood, CO.

Alessandro Orlando (A)

Department of Trauma Research, Swedish Medical Center, Englewood, CO.

Jeffrey Wagner (J)

Department of Neurology, Swedish Medical Center, Englewood, CO; Blue Sky Neurology, Englewood, CO.

David Bar-Or (D)

Department of Trauma Research, Swedish Medical Center, Englewood, CO. Electronic address: davidbme49@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH